GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving North Last Vegas, North Las Vegas: Medi-Slim Weight Loss & Spa, Kohn Medical & Weight Loss: Ronald Kohn, MD and Clinica Mi Pueblo - Las Vegas #2842. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
For North Last Vegas, North Las Vegas residents, the essentials on tirzepatide. Sold as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide stands out for its unique dual-hormone mechanism.
On a tight budget, many weigh a more affordable molecule against a lower maintenance dose - always under medical guidance. Price also shifts with the dose: the lowest titration steps usually cost less than the target maintenance dose.
In this state, Nevada Revised Statutes §629.515; the reference body is Nevada State Board of Medical Examiners. Around North Last Vegas, North Las Vegas in Clark County, 3 weight-management practice(s) are listed locally. Typical dosing: 2.5 - 5 - 7.5 - 10 - 12.5 - 15 mg/week, stepped up by tolerance and goal. With a local obesity rate around 30.6% and 11.0% uninsured, demand for Tirzepatide runs high around North Last Vegas, North Las Vegas.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.